Paul M Mathews Selected Research

Paul M Mathews Research Topics

Disease

47	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 02/2002
12	Amyloid Plaque 07/2015 - 04/2003
8	Amyloidosis 03/2016 - 08/2004
5	Down Syndrome (Down's Syndrome) 01/2019 - 09/2009
3	Memory Disorders (Memory Loss) 01/2023 - 08/2008
2	Cognitive Dysfunction 01/2019 - 06/2004
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2016 - 04/2010
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2016 - 02/2013
2	Dementia (Dementias) 04/2010 - 09/2004
2	Gliosis 09/2006 - 04/2003
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 09/2004 - 07/2004
1	Brain Injuries (Brain Injury) 01/2019
1	Epilepsy (Aura) 12/2016
1	Ischemia 12/2016
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2016
1	Diabetes Mellitus 04/2016
1	Insulin Resistance 04/2016
1	familial Danish Dementia 04/2010
1	Neuroinflammatory Diseases 04/2010
1	Hypercholesterolemia 08/2007
1	Amyloid angiopathy 09/2006
1	Hemorrhagic Stroke 09/2004
1	Familial Cerebral Amyloid Angiopathy 09/2004
1	Hydrocephalus (Hydrocephaly) 07/2004
1	Disease Progression 06/2004
1	Cerebral Hemorrhage 01/2004

Drug/Important Bio-Agent (IBA)

24	Amyloid (Amyloid Fibrils)IBA 01/2019 - 04/2003
21	Proteins (Proteins, Gene)FDA Link 01/2019 - 04/2003
18	Amyloid beta-PeptidesIBA 03/2016 - 04/2003
15	Peptides (Polypeptides)IBA 07/2015 - 10/2002
7	ApolipoproteinsIBA 01/2023 - 08/2004
5	Apolipoprotein E4IBA 01/2023 - 01/2017
5	Apolipoproteins E (ApoE)IBA 01/2023 - 08/2004
5	Cystatin CIBA 12/2016 - 01/2004
4	PresenilinsIBA 05/2013 - 10/2002
4	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 05/2013 - 10/2002
2	Apolipoprotein E2IBA 01/2023 - 01/2018
2	Apolipoprotein E3IBA 01/2023 - 01/2018
2	Peptide Hydrolases (Proteases)FDA Link 12/2016 - 05/2013
2	Insulin (Novolin)FDA Link 04/2016 - 02/2013
2	Presenilin-1IBA 11/2015 - 08/2007
2	Flavin-Adenine Dinucleotide (FAD)IBA 08/2007 - 06/2005
2	Amyloid beta-Protein Precursor (Amyloid Protein Precursor)IBA 06/2005 - 09/2004
2	Cysteine Proteases (Cysteine Protease)IBA 09/2004 - 01/2004
2	HydrolasesIBA 08/2004 - 02/2002
1	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 01/2019
1	Neprilysin (Neutral Endopeptidase)IBA 04/2016
1	Insulin Receptor Substrate ProteinsIBA 04/2016
1	Streptozocin (Streptozotocin)FDA Link 04/2016
1	Cholinergic Agents (Cholinergics)IBA 03/2016
1	EnzymesIBA 03/2016
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 07/2015
1	Coloring Agents (Dyes)IBA 07/2015
1	pentamer formyl thiophene acetic acidIBA 07/2015
1	calpastatinIBA 06/2012
1	Metalloproteases (Metalloproteinases)IBA 08/2011
1	Aspartic Acid ProteasesIBA 08/2011
1	Therapeutic UsesIBA 07/2011
1	GangliosidesIBA 11/2009
1	Messenger RNA (mRNA)IBA 09/2009
1	CalpainIBA 08/2008
1	Transcription Factors (Transcription Factor)IBA 08/2008
1	calpain inhibitorsIBA 08/2008
1	Synapsins (Synapsin I)IBA 08/2008
1	PrionsIBA 09/2006
1	IsoprostanesIBA 08/2004
1	Protein Isoforms (Isoforms)IBA 08/2004
1	Pioglitazone (Actos)FDA Link 07/2004
1	Serum Amyloid P-ComponentIBA 07/2004
1	thioflavin TIBA 07/2004
1	Transforming Growth Factors (Transforming Growth Factor)IBA 07/2004
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 07/2004
1	Indicators and Reagents (Reagents)IBA 06/2004
1	IonsIBA 11/2003
1	VaccinesIBA 07/2003
1	CholesterolIBA 07/2003
1	Gamma Secretase Inhibitors and ModulatorsIBA 10/2002
1	Mannose (D-Mannose)IBA 02/2002
1	CationsIBA 02/2002

Therapy/Procedure

1	Injections 04/2016
1	Immunotherapy 01/2013
1	Therapeutics 07/2004